First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.
Shigeo ShimoseAtsushi HiraokaMasahito NakanoHideki IwamotoMasatoshi TanakaTakaaki TanakaKazunori NoguchiHajime AinoKei OgataMasahiko KajiwaraSatoshi ItanoYoshinori YokokuraTaizo YamaguchiHiroshi KawanoNorito MatsukumaHideya SugaTakashi NiizekiTomotake ShironoYu NodaNaoki KamachiShusuke OkamuraTakumi KawaguchiHironori KogaTakuji TorimuraPublished in: Cancer medicine (2021)
Sequential therapy with SORA as the first-line treatment improved the prognosis of unresectable HCC patients and was effective regardless of HCC etiology.